Latest Industry Articles
Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China
Fapon, a leading life sciences company, entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA, that granted Fapon an exclusive license to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. This strategic partne
Read moreWorld Sepsis Day: Understanding Symptoms Better
World Sepsis Day falls on September 13. Sepsis, which kills more people in Austria each year than heart attacks, is caused by an infection which spreads through the body and damages our organs. A lot of people in the general public still do not know very much about this issue. Sepsis is
Read moreAbionic Receives IVDR Certification for Its Predictive Ultra-Rapid Sepsis Test
BSI certification agency has granted Abionic’s abioSCOPE® device and PSP test the IVDR certification for in-vitro diagnostics. This certification complies with Europe’s new In-vitro Diagnostic Regulation (IVDR), and will be required for products sold within the EU from May 2022 onward. A transiti
Read moreAbionic Webinar - Advancing the Diagnosis of Sepsis in the Intensive Care Units
Real world evidence on the practical implementation of the Pancreatic Stone Protein (PSP) Sepsis Test On the 22nd of September, attendees tuned in to a lively discussion on sepsis chaired by Professor Pedro Póvoa, who is currently coordinator of the Intensive Care Unit (ICU) in one of the
Read morePancreatic Stone Protein found to be an Early Marker for Risk Stratification in Acute Pancreatitis
Context Growing numbers of obesity, alcohol abuse and gallstones are leading to an increase in the incidence of acute pancreatitis. This sudden inflammatory disease of the pancreas usually requires hospitalization due to high mortality and morbidity rates. In some cases, acute pancreatitis can pro
Read moreNew Data Confirms the Clinical Benefit of PSP for the Diagnosis of Severe Infections
Critical Care, the top-ranked open access journal in the field of critical care medicine, published the results of a study led by Lausanne University Hospital’s Dr Philippe Eggimann and Bern University Hospital’s Dr Yok-Ai Que this month [1]. The authors analyzed pooled data from five cohorts showi
Read moreThe PSP Biomarker Rises Earlier than CRP and PCT in Sepsis, a New Study Shows
Sepsis is a global healthcare problem, with 50 million cases each year and 11 million related deaths 1 . It’s the life-threatening complication of an infection, in which the host’s immune response to a pathogen damages its own organs. The clinical diagnosis of sepsis relies mostly on signs an
Read moreGreat Symposium on the PSP Sepsis Biomarker - Hosted By Abionic and Palex at the GALISEPSIS 2021
On April 6th, Abionic and Palex joined forces to participate in the first day of GaliSepsis, the National Sepsis Course hosted and organized virtually by the Ourense University Hospital Complex (CHUO) in Spain. With the aim of updating the most important concepts and reviewing the latest developme
Read moreOrtho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available
Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received CE Mark for its VITROS ® B•R•A•H•M•S PCT (Procalcitonin) assay, now commercially available to help clinicians identify sepsis and othe
Read moreAtrial Fibrillation and Sepsis: A Life-Threatening Combination
Almost half of the patients with sepsis suffer from myocardial depression and a reduced ejection fraction. Sepsis can also cause changes in circulating volume, vascular tone, and coronary blood flow, all of which affect heart function and heart rate. Serum catecholamine levels and direct measuremen
Read more